In the Pink Sheet, Catalyst’s Nancy Myers commends how “Marks and Woodcock recognize they can’t be both referee and player” as they recuse themselves from reviewing COVID-19 products while working on Operation Warp Speed. She says, “The recusal is a step to protect the FDA’s reputation so people see it as an unbiased and scientifically based organization.”

Read the full article here (subscription required).